Arbutus Biopharma
-
Warminster-Founded Arbutus Biopharma to Receive $190M in Moderna Settlement
Four years after suing Moderna over its Covid-19 vaccine, Arbutus Biopharma, which was formerly headquartered in Warminster, has secured a $190 million share of a…
-
Doylestown’s Pennsylvania Biotech Center Recruits Hepatitis C Cure Inventor
Michael J. Sofia, the inventor of the Hepatitis C cure, has joined the Pennsylvania Biotechnology Center in Doylestown, working towards a cure for Hepatitis B,…
-
Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters
Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while continuing its pursuit of a hepatitis…
-
Mike Sofia, Scientist Behind Hepatitis C Drug, Retires from Warminster-Based Arbutus Biopharma
Mike Sofia, a renowned scientist, is set to retire as Chief Scientific Officer at Warminster-based Arbutus Biopharma by the end of the year, writes John…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
